377 related articles for article (PubMed ID: 24310723)
1. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
[TBL] [Abstract][Full Text] [Related]
2. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
Zaidi N; Royaux I; Swinnen JV; Smans K
Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Taguchi R; Soga T; Seimiya H
Am J Pathol; 2013 May; 182(5):1800-10. PubMed ID: 23506848
[TBL] [Abstract][Full Text] [Related]
4. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
Burke AC; Huff MW
Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
[TBL] [Abstract][Full Text] [Related]
5. In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.
Siculella L; Giannotti L; Testini M; Gnoni GV; Damiano F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054087
[TBL] [Abstract][Full Text] [Related]
6. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
[TBL] [Abstract][Full Text] [Related]
7. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
Xin M; Qiao Z; Li J; Liu J; Song S; Zhao X; Miao P; Tang T; Wang L; Liu W; Yang X; Dai K; Huang G
Oncotarget; 2016 Jul; 7(28):44252-44265. PubMed ID: 27317765
[TBL] [Abstract][Full Text] [Related]
8. ATP-citrate lyase: a key player in cancer metabolism.
Zaidi N; Swinnen JV; Smans K
Cancer Res; 2012 Aug; 72(15):3709-14. PubMed ID: 22787121
[TBL] [Abstract][Full Text] [Related]
9. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
10. Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism.
Shah S; Carriveau WJ; Li J; Campbell SL; Kopinski PK; Lim HW; Daurio N; Trefely S; Won KJ; Wallace DC; Koumenis C; Mancuso A; Wellen KE
Oncotarget; 2016 Jul; 7(28):43713-43730. PubMed ID: 27248322
[TBL] [Abstract][Full Text] [Related]
11. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
12. ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition.
Guo W; Ma J; Yang Y; Guo S; Zhang W; Zhao T; Yi X; Wang H; Wang S; Liu Y; Dai W; Chen X; Shi Q; Wang G; Gao T; Li C
Clin Cancer Res; 2020 Jun; 26(11):2725-2739. PubMed ID: 32034077
[TBL] [Abstract][Full Text] [Related]
13. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells.
Chu KY; Lin Y; Hendel A; Kulpa JE; Brownsey RW; Johnson JD
J Biol Chem; 2010 Oct; 285(42):32606-15. PubMed ID: 20693577
[TBL] [Abstract][Full Text] [Related]
14. ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation.
Tian M; Hao F; Jin X; Sun X; Jiang Y; Wang Y; Li D; Chang T; Zou Y; Peng P; Xia C; Liu J; Li Y; Wang P; Feng Y; Wei M
Elife; 2021 Sep; 10():. PubMed ID: 34491895
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
[TBL] [Abstract][Full Text] [Related]
16. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
Migita T; Narita T; Nomura K; Miyagi E; Inazuka F; Matsuura M; Ushijima M; Mashima T; Seimiya H; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y
Cancer Res; 2008 Oct; 68(20):8547-54. PubMed ID: 18922930
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
18. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
[TBL] [Abstract][Full Text] [Related]
19. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
[TBL] [Abstract][Full Text] [Related]
20. Adenosine Triphosphate Citrate Lyase and Fatty Acid Synthesis Inhibition: A Narrative Review.
Duarte Lau F; Giugliano RP
JAMA Cardiol; 2023 Sep; 8(9):879-887. PubMed ID: 37585218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
